The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|13|8|1174-1183

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.13, Iss.8, 2012-10, pp. : 1174-1183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. : 1905-1922

Bentham Science Publishers

Access to resources Recommend Favorite

Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-01 ,pp. : 3077-3090

Bentham Science Publishers

Access to resources Recommend Favorite

HIV protease inhibitors: present and future

By Pizzocolo Cecilia   Castagna Antonella   Lazzarin Adriano  

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 571-580

Future Medicine

Access to resources Recommend Favorite

HIV-1 Reverse Transcriptase Inhibitors: Current Issues and Future Perspectives

By  

Current Drug Metabolism, Vol. 5, Iss. 4, 2004-08 ,pp. : 283-290

Bentham Science Publishers

Access to resources Recommend Favorite

Current Development on HIV-1 Protease Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 3, Iss. 3, 2007-09 ,pp. : 201-213

Bentham Science Publishers

Access to resources Recommend Favorite